CLC Number:
| [1] |
Ramos-Casals M, Brito-Zerón P, López-Guillermo A, et al. Adult haemophagocytic Syndrome[J]. Lancet, 2014,383(9927):1503-1516.
doi: 10.1016/S0140-6736(13)61048-X pmid: 24290661 |
| [2] |
黄文秋, 王旖旎, 王晶石, 等. 192例成人噬血细胞淋巴组织细胞增生症患者的临床分析[J]. 中华血液学杂志, 2014,35(9):796-801.
doi: 10.3760/cma.j.issn.0253-2727.2014.09.003 |
| [3] |
Atteritano M, David A, Bagnato G, et al. Haemophagocytic syndrome in rheumatic patients. A systematic review[J]. Eur Rev Med Pharmacol Sci, 2012,16(10):1414-1424.
pmid: 23104659 |
| [4] |
Ahn SS, Yoo BW, Jung SM, et al. In-hospital mortality in febrile lupus patients based on 2016 EULAR/ACR/PRINTO classificationcriteria for macrophage activation syndrome[J]. Semin Arthritis Rheum, 2017,47(2):216-221.
doi: 10.1016/j.semarthrit.2017.02.002 pmid: 28268026 |
| [5] |
Ravelli A, Minoia F, Davì S, et al. 2016 classification criteria for macrophage activation syndrome complicating systemic juve-nile idiopathic arthritis: A European League Against Rheumatism / American College of Rheumatology / Paediatric Rheumatology International Trials Organisation Collaborative Initiative[J]. Ann Rheum Dis, 2016,75(3):481-489.
pmid: 26865703 |
| [6] |
Ahn SS, Yoo BW, Jung SM, et al. Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease[J]. J Rheumatol, 2017,44(7):996-1003.
doi: 10.3899/jrheum.161286 pmid: 28412707 |
| [7] |
Liu AC, Yang Y, Li MT, et al. Macrophage activation syndrome in systemic lupus erythematosus: A multicenter, case-controlstudy in China[J]. Clin Rheumatol, 2018,37(1):93-100.
pmid: 28409239 |
| [8] |
Zhang M, Behrens EM, Atkinson TP, et al. Genetic defects in cytolysis in macrophage activation syndrome[J]. Curr Rheumatol Rep, 2014,16(9):439.
doi: 10.1007/s11926-014-0439-2 pmid: 25086802 |
| [9] |
Wang Y, Wang Z, Zhang J, et al. Genetic features of late onset primary hemophagocytic lymphohistiocytosis in adolescence or adulthood[J]. PLoS One, 2014,9(9):e107386.
doi: 10.1371/journal.pone.0107386 pmid: 25233452 |
| [10] |
Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007,48(2):124-131.
doi: 10.1002/pbc.21039 pmid: 16937360 |
| [11] |
Davì S, Minoia F, Pistorio A, et al. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis[J]. Arthritis Rheumatol, 2014,66(10):2871-2880.
doi: 10.1002/art.38769 pmid: 25044674 |
| [12] |
Ravelli A, Magni-Manzoni S, Pistorio A, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juve-nile idiopathic arthritis[J]. J Pediatr, 2005,146(5):598-604.
doi: 10.1016/j.jpeds.2004.12.016 pmid: 15870661 |
| [13] |
La Rosee P, Horne A, Hines M, et al. Recommendations of the management of hemophagocytic lymphohistiocytosis in adults[J]. Blood, 2019,133(23):2465-2477.
doi: 10.1182/blood.2018894618 pmid: 30992265 |
| [14] |
Tada Y, Inokuchi S, Maruyama A, et al. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still’s disease?[J]. Rheumatol Int, 2019,39(1):97-104.
doi: 10.1007/s00296-018-4114-1 pmid: 30051293 |
| [15] |
Minoia F, Bovis F, Davì S, et al. Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis[J]. Ann Rheum Dis, 2019,78(10):1357-1362.
doi: 10.1136/annrheumdis-2019-215211 pmid: 31296501 |
| [16] | Wang R, Li T, Ye S, et al. Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease [J/OL]. Ann Rheum Dis, (2019-10-14) [2020-06-25]. doi: 10.1136/annrheumdis-2019-216286. |
| [17] | 姚海红, 王旖旎, 张霞, 等. 67例成人巨噬细胞活化综合征的临床特征及治疗转归[J]. 北京大学学报(医学版), 2019,51(6):996-1002. |
| [18] |
Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy[J]. Nat Rev Rheumatol, 2016,12(5):259-268.
doi: 10.1038/nrrheum.2015.179 pmid: 27009539 |
| [19] |
Weiss ES, Girard-Guyonvarc’h C, Holzinger D, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome[J]. Blood, 2018,131(13):1442-1455.
doi: 10.1182/blood-2017-12-820852 pmid: 29326099 |
| [1] | Pu-li ZHANG,Hong-xia YANG,Li-ning ZHANG,Yong-peng GE,Qing-lin PENG,Guo-chun WANG,Xin LU. Value of serum YKL-40 in the diagnosis of anti-MDA5-positive patients with dermatomyositis complicated with severe pulmonary injury [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1055-1060. |
| [2] | Lan LUO,Xiao-yan XING,Yun-shu XIAO,Ke-yan CHEN,Feng-yun-zhi ZHU,Xue-wu ZHANG,Yu-hui LI. Clinical and immunological characteristics of patients with anti-synthetase syndrome complicated with cardiac involvement [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1078-1082. |
| [3] | Xue LOU,Li LIAO,Xing-jun LI,Nan WANG,Shuang LIU,Ruo-mei CUI,Jian XU. Methylation status and expression of TWEAK gene promoter region in peripheral blood of patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1020-1025. |
| [4] | Hua ZHONG,Li-ling XU,Ming-xin BAI,Yin SU. Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1026-1031. |
| [5] | Liang LUO,Wen-gang HUO,Qin ZHANG,Chun LI. Clinical characteristics and risk factors of rheumatoid arthritis with ulcerative keratitis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1032-1036. |
| [6] | Xue-rong DENG,Xiao-ying SUN,Zhuo-li ZHANG. Agreement between ultrasound-detected inflammation and clinical signs in ankles and feet joints in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1037-1042. |
| [7] | Guang-yan MENG,Yun-xiao ZHANG,Yu-xin ZHANG,Yan-ying LIU. Clinical characteristics of central nervous system involvement in IgG4 related diseases [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1043-1048. |
| [8] | Lu ZHANG,Xiao-hong HU,Cheng CHEN,Yue-ming CAI,Qing-wen WANG,Jin-xia ZHAO. Analysis of cervical instability and clinical characteristics in treatment-naive rheumatoid arthritis patients [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1049-1054. |
| [9] | Zhi-bo SONG,Yan GENG,Xue-rong DENG,Xiao-hui ZHANG,Zhuo-li ZHANG. Benefit of ultrasound in the phenotype recognition of psoriatic arthritis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1061-1066. |
| [10] | Jia-yi TIAN,Xia ZHANG,Gong CHENG,Qing-hong LIU,Shi-yang WANG,Jing HE. Serum interleukin-2 receptor α as a clinical biomarker in patients with systemic lupus erythematosus [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1083-1087. |
| [11] | Ying-jue DU,Wei-chao LIU,Xi CHEN,Yong-jing CHENG. A case report of colchicine-induced myopathy in a patient with chronic kidney disease [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1188-1190. |
| [12] | Wen-xia YI,Cui-jie WEI,Ye WU,Xin-hua BAO,Hui XIONG,Xing-zhi CHANG. Long-term rituximab treatment of refractory idiopathic inflammatory myopathy: A report of 3 cases [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1191-1195. |
| [13] | Yun-shu XIAO,Feng-yun-zhi ZHU,Lan LUO,Xiao-yan XING,Yu-hui LI,Xue-wu ZHANG,Dan-hua SHEN. Clinical and immunological characteristics of 88 cases of overlap myositis [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1088-1093. |
| [14] | . [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 1012-1016. |
| [15] | Zheng-fang LI,Xue WU,Li-jun WU,Cai-nan LUO,Ya-mei SHI,Yan ZHONG,Xiao-mei CHEN,Xin-yan MENG. Clinical features of patients with Rhupus syndrome [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 933-937. |